Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Clinical trial NCT05174169 · RECRUITING

Trial details

NCT number: NCT05174169
Sponsor: NRG Oncology
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Stage III Colon Cancer

Start date: 2022-07-08
Primary completion: 2029-03-10
Enrollment: 1912

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.